Tag: Merck
Merck To Buy Acceleron For $11.5B
Merck is buying Acceleron Pharma Ifor about US$11.5 billion, broadening its portfolio beyond aging cancer drug Keytruda with potential treatments that could bring in...
Merck, Pfizer’s Wyeth Settle Vaccine Patent Case
Merck Sharp & Dohme Corp and Pfizer's Wyeth subsidiary have resolved a patent dispute over their competing vaccines for preventing diseases including pneumonia and...
Merck’s Vaccine Antitrust Cases Can Proceed As Class Action
A lawsuit accusing Merck of illegally stifling competition for its rotavirus vaccine RotaTeq can proceed as a class action, a Philadelphia federal judge has...
Germany: Merck to buy Versum for US$6.56B
Merck announced Friday, April 12, it has signed a definitive agreement to acquire Versum Materials in a deal with an enterprise value of US$6.6...
Germany: Merck presses Versum sherholders to back its $4.5B bid
According the Financial Times, Merck has ramped up its efforts to torpedo the US$4.5 billion takeover of US chemicals group Versum Materials by Entegris,...
Germany: Pharma group Merck launches a hostile $5.9 billion for...
German pharma group Merck launched a hostile US$5.9 billion all-cash takeover offer for Versum Materials on Tuesday, March 26, to boost its presence in...
Germany: Merck makes US$5.9B counterbid for Versum
German drugs and lab supplies maker Merck offered US$5.9 billion, including debt, for Versum Materials, in a cash deal that tops an offer from...
US: Merck cannot arbitrate rotavirus vaccine antitrust claims
Three pediatric medical practices can proceed with a proposed class action accusing pharmaceutical company Merck of illegally stifling competition to its rotavirus vaccine RotaTeq...
US/Germany: P&G buys Merck health brands for $4.2B
Procter & Gamble (P&G) has agreed to buy the consumer health business of German drugmaker Merck for €3.4billion (US$4.2 billion), as the US group...
UK: Watchdog accuses Merck of breaking competition laws
Britain's competition watchdog has accused Merck of operating an unfair discount scheme for its medicine Remicade that it said was designed to restrict competition...
